Press Releases

DECEMBER 17, 2025 — CRN today announced results of its recent Board of Directors elections, effective in January 2026.

DECEMBER 11, 2025 — CRN today commended the U.S. Food and Drug Administration (FDA) and expressed the association’s appreciation for FDA providing needed clarity on the placement of the Dietary Supplement Health and Education Act (DSHEA) disclaimer on product labels.

NOVEMBER 20, 2025 — The CRN Foundation today announced the release of CRN’s updated Vitamin K2 (menaquinone-7, MK-7) chapter as part of the Vitamin & Mineral Safety, 4th Edition (VMS4). For the first time, CRN’s rigorous safety evaluation establishes a supplemental Highest Observed Intake (HOI) level of 375 µg/day for adults, offering essential new guidance for manufacturers, regulators, and health practitioners seeking evidence-based recommendations for this increasingly used nutrient.

NOVEMBER 13, 2025 — CRN expressed disappointment today after the U.S. Court of Appeals for the Second Circuit declined to grant a preliminary injunction to pause enforcement of a New York law restricting the sale of certain dietary supplements to individuals under 18.

OCTOBER 17, 2025 — CRN today announced the publication of three new and updated chapters in its Vitamin & Mineral Safety, Fourth Edition (VMS4) series—expanding the supplement industry’s most comprehensive, science-based resource on nutrient safety.

OCTOBER 9, 2025 — CRN and Radicle Science today announced the 2025 Annette Dickinson Trailblazer Award honoree, recognizing barrier-breaking contributions and leadership in the health and wellness industry. 

OCTOBER 6, 2025 — CRN today announced newly approved member companies following approval by its board of directors during its quarterly meeting in September.

OCTOBER 3, 2025 — CRN today announced a significant policy win in California with the enactment of S.B. 862. Signed by Governor Gavin Newsom on October 1, 2025, the legislation clarifies that dietary supplements are not subject to the state’s baby food testing and labeling requirements established under A.B. 899.

SEPTEMBER 29, 2025 — CRN today expressed strong disappointment in the U.S. Food and Drug Administration’s (FDA) decision to deny CRN’s citizen petition urging the agency to correct its flawed interpretation of the drug preclusion provision under Section 201(ff)(3)(B) of the Federal Food, Drug, and Cosmetic Act and provide the industry with reasonable, fair guidance regarding the provision's application to dietary supplements. 

SEPTEMBER 25, 2025 — CRN today released new data confirming that expanding Health Savings Accounts (HSAs), Flexible Spending Accounts (FSAs), and similar vehicles to cover dietary supplements would have a modest budget impact—just $12.2 billion over 10 years—while delivering enormous health benefits for consumers.